China's biotech increase reshapes pharma, sparks U.S. business issues

U.S. buyers and pharmaceutical giants are more and more trying to China for drug innovation, with practically 30% of main pharma offers final yr involving Chinese language corporations—up from 0% in 2019.

Supply hyperlink